The present invention relates to a system used in remote laboratory assays, having cartridge (C) with a reagent strip (TR) a reader (L) with a dedicated hardware (HDL) and a dedicated software (SDL), a local remote hardware (HRL) with a dedicated software (SDHL), an external served hardware (HES) with a data base (BD) and a dedicated software (SDS) and an external hardware with an access interface (HEIA) with an interface software connected to the Internet (SICI) and dedicated software (SDIA), which reads the parameters of the cartridge for collecting various types of biological samples and transmits data, allowing the data to be accessed remotely, with the advantages of being easy to use, of optimizing workflows, of being easy for users to learn, of allowing new exams to be easily and conveniently recorded, of being modular, compact, smaller, portable, ergonomic, user-friendly, intuitive, more practical and less expensive.

In an example, a method includes obtaining an expected biological sample value at a computing device. The expected biological sample value indicates an expected concentration of a material biologically processed by a courier. The computing device determines whether the measured biological sample value is associated with the courier based on a comparison of the expected biological sample value to the measured biological sample value. The method also includes determining a particular set of operations to be performed at the computing device based on a result of the comparison.

To reduce the risk of mistaken operation and improve convenience in an automatic analysis device. Information about types of measurement inputted from an input device is combined in an examination mode creation screen image 301 on a display device of an automatic analysis device that performs analysis of specific types of measurement on a specimen container accommodating a specimen, the information about types of measurement including biochemistry examination items 303, immunology examination items 304, ISE examination items 304, blood clotting examination items 306, etc. This information is associated with an examination mode name 302, which comprises discretionary setting information, and is stored in a table of a storage unit. Information which is to be displayed on the display device and for which a change in settings is to be enabled is limited on the basis of the stored information about types of measurement associated with the examination mode name 302.

Carriers are provided for microbiological laboratory use, as are methods for their use. The carriers may be used to transport patient samples between laboratory stations and can be loaded into automated AST systems. In an aspect, a method of performing AST may include loading a tube comprising a patient sample onto a carrier. An AST panel may be loaded onto the carrier. The carrier may be conveyed to an automated inoculation assembly. The patient sample may be inoculated from the tube into the AST panel. The AST panel may be loaded into an automated AST system.

A sample receptacle can be used for ordering assays to be performed by an automatic sample processing instrument. The sample receptacle can include a body defining a chamber for containing a sample and a label. The label can include discrete areas configured to be altered from a first assay order state to a second assay order state. Each discrete area has a known association with a different assay. The label can also include assay-identifying indicia indicating the respective assay associated with a respective discrete area. A method of processing a sample in a receptacle having one or more assay order states can include automatically determining assay order states of the discrete areas and performing an assay on the sample, using the automatic sample processing instruments, based on the determined assay order states of the discrete areas.

A flow cytometer according to one or more aspects may include: a particle data acquisition unit that measures particles in a sample to acquire particle data including optical information of the particles; and a transmission unit that transmits at least one of the particle data and data on a particle distribution diagram of the particles, generated based on the particle data, to at least one of a hospital information system that supports hospital operations and a clinical laboratory information system that supports clinical test operations.

The present disclosure pertains to the identification of novel biomarkers for the characterization of melanocytic lesions as can be found in skin diseases such as melanomas and psoriasis. In particular, the present invention is directed to a method for characterizing melanocytic lesions and their use in an automated or semi-automated device for the diagnosis and/or monitoring of benign, pre-malignant, and malignant melanocytic lesions, as further defined in the claims.

The present patent of invention relates to a reader device for biological samples used in the field of remote laboratory tests (TLR), for clinical diagnostic purposes, based on an optimized design constituted by a cowling (C) with inlet port (OE) and with switch (I); by a holding support (SS) containing a mirror (ES), two batteries (BT), two reading illumination arrays (BIL), operational status illumination arrays (BIS) and an elevator support (SE); by an elevator (EL); by an electronics board (PE) with energy loading circuit (PE-1), with supply circuit (PE-2), with processor (PE-3), with Bluetooth device (PE-4) and with position sensor (PE-5); and by a base (BA) with software that reads various types of biological samples, the present invention providing the advantages of: ease of use, optimized operating flows, ease of training, modularity, compactness, reduced size, portability, lightness of weight, ergonomic design, used-friendliness, enhanced practically and low cost

Disclosed herein are test substrates, systems and methods for detecting an analyte in a sample. Test substrates of the present disclosure include a predefined pattern, wherein a first region includes a partial pattern of the predefined pattern and a second region that is incomplete and wherein the incomplete portion comprises a reagent that reacts with an analyte in a sample to produce a completed pattern, wherein the completed pattern forms a code.

In some aspects, automated rapid antimicrobial susceptibility testing systems for performing a multi-assay testing sequence can include an automated incubation assembly having a nest assembly adapted to house at least one test panel having a plurality of wells for receiving a sample comprising microorganisms originating from a clinical sample, the incubation assembly facilitating incubation of one or more test panels in order to undergo the multi-assay testing sequence; a robotic handling assembly configured to accept one or more incoming test panels and move them to and from the incubation assembly for incubation between each assay of the multi-assay testing sequence; an automated liquid handling assembly configured to exchange one or more fluids in the plurality of wells of the test panels; and an optical assembly for interrogation and readout of each assay of the multi-assay testing sequence being performed in the plurality of wells.